PJP vs. BIS

Last updated Jun 4, 2026

PJP (Invesco Dynamic Pharmaceuticals ETF) and BIS (ProShares UltraShort Nasdaq Biotechnology) are both exchange-traded funds - PJP is a Health & Biotech Equities fund tracking the Dynamic Pharmaceuticals Intellidex Index, while BIS is a Leveraged Equities fund tracking the NASDAQ Biotechnology Index (-200%). Both are passively managed. Over the past 10 years, PJP returned 6.15%/yr vs -23.34%/yr for BIS. At a correlation of -0.81, they often move in opposite directions. PJP charges 0.58%/yr vs 0.95%/yr for BIS.

Performance

PJP vs. BIS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Dynamic Pharmaceuticals ETF (PJP) and ProShares UltraShort Nasdaq Biotechnology (BIS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, PJP achieves a 2.90% return, which is significantly higher than BIS's -6.36% return. Over the past 10 years, PJP has outperformed BIS with an annualized return of 6.15%, while BIS has yielded a comparatively lower -23.34% annualized return.

PJP

• 1D: 1.20%
• 1M: 1.29%
• YTD: 2.90%
• 6M: 2.29%
• 1Y: 34.73%
• 3Y*: 13.31%
• 5Y*: 7.62%
• 10Y*: 6.15%

BIS

• 1D: -3.65%
• 1M: 2.35%
• YTD: -6.36%
• 6M: -4.11%
• 1Y: -49.58%
• 3Y*: -21.43%
• 5Y*: -14.49%
• 10Y*: -23.34%

*Multi-year figures are annualized to reflect compound growth (CAGR)

PJP vs. BIS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
PJP Invesco Dynamic Pharmaceuticals ETF	2.90%	27.98%	9.63%	-2.18%	-2.16%	14.58%	11.29%	4.64%	-1.78%	15.30%
BIS ProShares UltraShort Nasdaq Biotechnology	-6.36%	-45.95%	4.79%	-6.54%	-2.14%	-14.74%	-56.01%	-41.01%	5.14%	-36.98%

Correlation

The correlation between PJP and BIS is -0.83, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.83
Correlation (3Y) Calculated over the trailing 3-year period	-0.81
Correlation (5Y) Calculated over the trailing 5-year period	-0.80
Correlation (10Y) Calculated over the trailing 10-year period	-0.81
Correlation (All Time) Calculated using the full available price history since Apr 9, 2010	-0.81

The correlation between PJP and BIS has been stable across timeframes, ranging from -0.83 to -0.80 - a consistent structural relationship.

Return for Risk

PJP vs. BIS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PJP

PJP Risk / Return Rank: 64
PJP Sharpe Ratio Rank: 63
PJP Sortino Ratio Rank: 64
PJP Omega Ratio Rank: 57
PJP Calmar Ratio Rank: 73
PJP Martin Ratio Rank: 63

BIS

BIS Risk / Return Rank: 1
BIS Sharpe Ratio Rank: 1
BIS Sortino Ratio Rank: 1
BIS Omega Ratio Rank: 1
BIS Calmar Ratio Rank: 1
BIS Martin Ratio Rank: 3

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PJP vs. BIS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and ProShares UltraShort Nasdaq Biotechnology (BIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PJP	BIS	Difference
Sharpe ratio: Return per unit of total volatility	2.13	-1.25	+3.38
Sortino ratio: Return per unit of downside risk	3.01	-1.99	+5.00
Omega ratio: Gain probability vs. loss probability	1.36	0.78	+0.57
Calmar ratio: Return relative to maximum drawdown	3.70	-0.91	+4.61
Martin ratio: Return relative to average drawdown	11.55	-1.25	+12.80
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PJP vs. BIS - Sharpe Ratio Comparison

The current PJP Sharpe Ratio is 2.13, which is higher than the BIS Sharpe Ratio of -1.25. The chart below compares the historical Sharpe Ratios of PJP and BIS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	PJP	BIS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.13	-1.25	+3.38
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.47	-0.33	+0.81
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.34	-0.50	+0.84
Sharpe Ratio (All Time) Calculated using the full available price history	0.59	-0.67	+1.26

Drawdowns

PJP vs. BIS - Drawdown Comparison

The maximum PJP drawdown since its inception was -37.06%, smaller than the maximum BIS drawdown of -99.87%. Use the drawdown chart below to compare losses from any high point for PJP and BIS.

Drawdown Indicators

	PJP	BIS	Difference
Max Drawdown Largest peak-to-trough decline	-37.06%	-99.87%	+62.81%
Max Drawdown (1Y) Largest decline over 1 year	-9.44%	-54.50%	+45.06%
Max Drawdown (3Y) Largest decline over 3 years	-16.27%	-66.87%	+50.60%
Max Drawdown (5Y) Largest decline over 5 years	-17.51%	-74.80%	+57.29%
Max Drawdown (10Y) Largest decline over 10 years	-33.95%	-95.25%	+61.30%
Current Drawdown Current decline from peak	-2.94%	-99.85%	+96.91%
Average Drawdown Average peak-to-trough decline	-8.85%	-90.03%	+81.18%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.02%	39.59%	-36.57%

Volatility

PJP vs. BIS - Volatility Comparison

The current volatility for Invesco Dynamic Pharmaceuticals ETF (PJP) is 5.33%, while ProShares UltraShort Nasdaq Biotechnology (BIS) has a volatility of 13.87%. This indicates that PJP experiences smaller price fluctuations and is considered to be less risky than BIS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PJP	BIS	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.33%	13.87%	-8.54%
Volatility (6M) Calculated over the trailing 6-month period	12.02%	30.95%	-18.93%
Volatility (1Y) Calculated over the trailing 1-year period	16.38%	39.68%	-23.30%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.17%	43.74%	-27.57%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.39%	46.36%	-27.97%

PJP vs. BIS - Expense Ratio Comparison

PJP has a 0.58% expense ratio, which is lower than BIS's 0.95% expense ratio.

Dividends

PJP vs. BIS - Dividend Comparison

PJP's dividend yield for the trailing twelve months is around 0.99%, less than BIS's 4.92% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BIS ProShares UltraShort Nasdaq Biotechnology	4.92%	5.25%	3.73%	1.75%	0.00%	0.00%	0.45%	2.11%	0.37%	0.00%	0.00%	0.00%
PJP Invesco Dynamic Pharmaceuticals ETF	0.99%	0.98%	0.97%	1.01%	0.95%	0.81%	0.75%	0.77%	1.12%	0.65%	0.91%	5.49%

Frequently Asked Questions

Can I hold both PJP and BIS in my portfolio?

PJP and BIS have a correlation of -0.83, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, PJP or BIS?

BIS has higher volatility (13.87%) compared to PJP (5.33%). In terms of maximum drawdown, PJP dropped -37.06% vs BIS's -99.87%.

Which ETF is better, PJP or BIS?

On 10-year performance, PJP leads with 6.15% vs -23.34% for BIS. On fees, PJP is cheaper at 0.58% per year. On volatility, PJP has been the lower-risk option at 5.33%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, PJP or BIS?

Over the 10-year period, PJP has performed better with a 6.15% return vs -23.34%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, PJP or BIS?

PJP is cheaper with a 0.58% expense ratio, compared with 0.95% for BIS.

Which ETF pays a higher dividend yield, PJP or BIS?

BIS has the higher dividend yield at 4.92%, compared with 0.99% for PJP.

What is the main difference between PJP and BIS?

PJP is categorized as Health & Biotech Equities, while BIS is Leveraged Equities. PJP tracks Dynamic Pharmaceuticals Intellidex Index, while BIS tracks NASDAQ Biotechnology Index (-200%). They also come from different issuers: Invesco and ProShares. Their fees differ too: 0.58% for PJP and 0.95% for BIS.

Which has better risk-adjusted returns?

PJP currently has the higher Sharpe Ratio (2.13 vs -1.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.